| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |